Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.

about

Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators.

P2860

Q27693421-1FF04A00-B752-46FF-B9FA-C947AF6856E3 Q55188503-6F13206A-AF36-43B0-BC27-650EF3053585

P2860

Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.

Item

http://www.wikidata.org/entity/Q38098476

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacovigilance systems in d ...... ve case study in Burkina Faso.

@en

type

Item

label

Pharmacovigilance systems in d ...... ve case study in Burkina Faso.

@en

prefLabel

Pharmacovigilance systems in d ...... ve case study in Burkina Faso.

@en

P1476

Pharmacovigilance systems in d ...... ve case study in Burkina Faso.

@en

P2093

Caroline Adam

http://www.w3.org/2001/XMLSchema#string

Driss Berdai

http://www.w3.org/2001/XMLSchema#string

Françoise Haramburu

http://www.w3.org/2001/XMLSchema#string

Lassane Kabore

http://www.w3.org/2001/XMLSchema#string

Pascal Millet

http://www.w3.org/2001/XMLSchema#string

Souleymane Fofana

http://www.w3.org/2001/XMLSchema#string

P2860

Mediator scandal rocks French medical community

Pharmacovigilance in perspective.

Differences between clinical trials and postmarketing use.

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital

Antimalarial drug quality in Africa

Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria.

Determinants of under-reporting of adverse drug reactions: a systematic review.

Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.

When rumours derail a mass deworming exercise.

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.

P2888

s40264-013-0043-9

P304

349-358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40264-013-0043-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236196695

http://www.w3.org/2001/XMLSchema#string

P6179

1050804202

http://www.w3.org/2001/XMLSchema#string

P698

23580195

http://www.w3.org/2001/XMLSchema#string

P921

Burkina Faso

Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.

about

P2860

P2860

Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921